RSS-Feed abonnieren
Bitte kopieren Sie die angezeigte URL und fügen sie dann in Ihren RSS-Reader ein.
https://www.thieme-connect.de/rss/thieme/de/10.1055-s-00000084.xml
PDF herunterladen
Synthesis 2017; 49(12): 2768-2774
DOI: 10.1055/s-0036-1588752
DOI: 10.1055/s-0036-1588752
paper
First Total Synthesis of a Cytotoxic Derivative of the Natural Product Aaptamine
Autoren
Weitere Informationen
Publikationsverlauf
Received: 02. Januar 2017
Accepted after revision: 24. Februar 2017
Publikationsdatum:
17. März 2017 (online)
Abstract
A synthetic sequence to the benzonaphthyridinone framework is described. The key step is a one-pot, base-catalyzed vicarious nucleophilic substitution followed by ring closure. Additionally, the synthesis represents the application of a vicarious nucleophilic substitution in the total synthesis of a cytotoxic aaptamine derivative.
Key words
total synthesis - heterocycles - vicarious aromatic substitution - cyclization - alkylationSupporting Information
- Supporting information for this article is available online at http://dx.doi.org/10.1055/s-0036-1588752.
- Supporting Information (PDF) (opens in new window)
-
References
- 1 Blunt JW, Copp BR, Keyzers RA, Munro MH. G, Prinsep MR. Nat. Prod. Rep. 2016; 33: 382-382
- 2 Larghi EL, Bohn ML, Kaufman TS. Tetrahedron 2009; 65: 4257-4257
- 3 Nakamura H, Kobayashi J, Ohizumi Y, Hirata Y. J. Chem. Soc., Perkin Trans. 1 1987; 173-173
- 4a Utkina NK. Chem. Nat. Compd. 2009; 45: 849-849
- 4b Lv Z, Wang HS, Niu XD. Chem. Phys. Lett. 2013; 585: 171-171
- 4c Bowling JJ, Pennaka HK, Ivey K, Wahyuono S, Kelly M, Schinazi RR, Valeriote FA, Graves DE, Hamann MT. Chem. Biol. Drug. Des. 2008; 71: 205-205
- 4d Kim MJ, Woo SW, Kim MS, Park JE, Hwang JK. J. Asian Nat. Prod. Res. 2014; 16: 1139-1139
- 4e Dyshlovoy SA, Fedorov SN, Shubina LK, Kuzmich AS, Bokemeyer C, Keller-von Amsberg G, Honecker F. Biomed. Res. Int. 2014; 469309-469309
- 4f Murniasih T, Kosela S, Kardono LB. S, Priyono W. Asian J. Biotech. 2013; 5: 21-21
- 4g Pettit GR, Herald DL, Hoffman H. US Patent 20050187240 A1, 2005
- 4h Yu HB, Yang F, Sun F, Li J, Jiao WH, Gan JH, Hu WZ, Lin HW. Mar. Drugs 2014; 12: 6003-6003
- 4i Zalilawati MR, Andriani Y, Shaari K, Bourgougnon N, Ali AM, Muhammad TS. T, Mohamad H. J. Chem. Pharm. Res. 2015; 7: 330-330
- 4j Gan JH, Hu WZ, Yu HB, Yang F, Cao MX, Shi HJ, Kang YF, Han BN. J. Asian Nat. Prod. Res. 2015; 17: 1231-1231
- 4k Li QL, Zhang PP, Wang PQ, Yu HB, Sun F, Hu WZ, Wu WH, Zhang X, Chen F, Chu ZY. Anti-Cancer Agents Med. Chem. 2015; 15: 1-1
- 4l Stuhldreier F, Kassel S, Schumacher L, Wesselborg S, Proksch P, Fritz G. Cancer Lett. 2015; 361: 39-39
- 4m Diers JA, Ivey KD, Shaikh EA, Wang J, Kochanowska AJ, Stoker JF, Hamann MT, Matsumoto RR. Pharmacol. Biochem. Behav. 2008; 89: 46-46
- 5a Sugino E, Choshi T, Hibino S. Heterocycles 1999; 50: 543-543
- 5b Pettit GR, Hoffmann H, Herald DL, McNulty J, Murphy A, Higgs KC, Hamel E, Lewin NE, Pearce LV, Blumberg PM. J. Org. Chem. 2004; 69: 2251-2251
- 5c Abbiati G, Doda A, Dell’Acqua M, Pirovano V, Facoetti D, Rizzato S, Rossi E. J. Org. Chem. 2012; 77: 10461-10461
- 5d Heredia DA, Larghi EL, Kaufman TS. Eur. J. Org. Chem. 2016; 1397-1397
- 6 Yu H, Yang F, Sun F, Ma G, Gan J, Hu W, Han B, Jiao W, Lin H. J. Nat. Prod. 2014; 77: 2124-2124
- 7a Radchenko OS, Sigida EN, Balaneva NN, Dmitrenok PS, Novikov VL. J. Heterocycl. Chem. 2011; 48: 209-209
- 7b Blake JF, Brandhuber BJ, Haas J, Newhouse B, Thomas AA, Winski SL. Patent WO201478331, 2014
- 7c Henrie RN, Peake CJ, Cullen TG, Lew AC, Chaguturu MK, Ray PS, Yeager WH, Silverman IR, Buser JW. US Patent US5534518, 1996
- 7d Hadida S, Van Goor F, Zhou J, Arumugam V, McCartney J, Hazlewood A, Decker C, Negulescu P, Grootenhuis PD. J. Med. Chem. 2014; 57: 9776-9776
- 7e Sakamoto T, Miura N, Kondo Y, Yamanaka H. Chem. Pharm. Bull. 1986; 34: 2760-2760
- 7f Zhao X, Xin M, Huang W, Ren Y, Jin Q, Tang F, Jiang H, Wang Y, Yang J, Mo S. Bioorg. Med. Chem. 2015; 23: 348-348
- 8 Baker-Glenn C, Chambers M, Chan BK, Estrada A, Sweeney ZK. Patent WO201379505, 2013
- 9a Beaulieu PL, Brochu C, Chabot C, Jolicoeur E, Kawai S, Poupart M, Tsantrizos YS. Patent WO200465367 A1, 2004
- 9b Wierlacher S, Sander W, Liu MT. H. J. Am. Chem. Soc. 1993; 115: 12305-12305
- 9c Wurtz NR, Priestley ES, Cheney DL, Zhang X, Parkhurst B, Ladziata V. Patent WO200879836 A2, 2008
- 10 Yang W, Li L, Wang Y, Wu X, Li T, Yang N, Su M, Sheng L, Zheng M, Zang Y. Bioorg. Med. Chem. 2015; 23: 5881-5881
- 11a Yuan Y, Zaidi SA, Stevens DL, Scoggins KL, Mosier PD, Kellogg GE, Dewey WL, Selley DE, Zhang Y. Bioorg. Med. Chem. 2015; 23: 1701-1701
- 11b Drewry JA, Fletcher S, Hassan H, Gunning PT. Org. Biomol. Chem. 2009; 7: 5074-5074
- 11c Talamas FX, Abbot SC, Anand S, Brameld KA, Carter DS, Chen J, Davis D, de Vicente J, Fung AD, Gong L. J. Med. Chem. 2014; 57: 1914-1914
- 12 Jin MJ, Lee DH. Angew. Chem. Int. Ed. 2010; 49: 1119-1119
- 13a Krapcho AP, Jahngen EG. E, Lovey AJ. Jr. Tetrahedron Lett. 1974; 13: 1091-1091
- 13b Wagner J, von Matt P, Faller B, Cooke NG, Albert R, Sedrani R, Wiegand H, Jean C, Beerli C, Weckbecker G. J. Med. Chem. 2011; 54: 6028-6028
- 14a Pagoria PF, Mitchell AR, Schmidt RD. J. Org. Chem. 1996; 61: 2934-2934
- 14b Shinzo S, Kunihito M, Norio K. J. Chem. Soc., Perkin Trans. 1 1999; 1437-1437
- 15a Chen YH, Zhang YH, Zhang HJ, Liu DZ, Gu M, Li JY, Wu F, Zhu X, Li J, Nan F. J. Med. Chem. 2006; 49: 613-613
- 15b Dworczak R, Sterk H, Junek H. Monatsh. Chem. 1990; 121: 189-189
- 15c Kitahara Y, Mochii M, Mori M, Kubo A. Tetrahedron 2003; 59: 2885-2885
- 15d Yoshifuji S, Arakawa Y. Chem. Pharm. Bull. 1989; 37: 3380-3380
- 15e Zipple S, Boldt P. Synthesis 1997; 173-173
- 16 Morel AF, Larghi EL, Selvero MM. Synlett 2005; 2755-2755